Ming capital
Venture capitalShenzhen · Seed–Late Stage · 6 people tracked
Find your way into Ming capital
1 people in our graph share verified history with the Ming capital team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Ming Capital is a healthcare-focused venture capital firm dedicated to improving human health by backing medical breakthroughs, particularly in innovative medicine, medical devices, and in-vitro diagnostics. It aims to connect global resources across medical innovation, entrepreneurship, management, commercial markets, and capital markets through parallel onshore-offshore funds and parallel investments. The firm supports entrepreneurs developing world-leading technologies and invests across geographies including China, the US, Israel, and Europe.
Source: firm website, verified Aug 30, 2026.
Team · 6 people
from the firm's website & public directoriesWhat they invest in
from 8 of 17 portfolio companiesHardware ×5Medical Devices ×5Healthtech ×4Deep Tech ×2Media & Entertainment ×2Biotech ×1Digital Health ×1Fintech ×1
HQs:China×4United Kingdom×1Israel×1United States×1
Investments · 17 tracked
founders shown can be your intro pathGuangzhou-based developer of small molecule drugs for lymphoma, lung cancer, and ovarian cancer, including BEBT-908, a dual-target drug for recurrent or refractory lymphoma.
Caretaker Medical develops wireless medical devices for non-invasive continuous hemodynamic monitoring using patented Pulse Decomposition Analysis technology.
Digital HealthHardwareHealthtechMedical DevicesCharlottesville, US
Martin Baruch(Executive Officer, Director)inJeff Pompeo(Executive Officer, Director, Promoter)inTodd Hochrein(Executive Officer, Director)in
BoardMark Rausch(Director)inPaul Jansen(Director)Rolf Hueppi(Director)
Co-investorsEarly Light VenturesIrishAngelsRiptide Ventures
Edadoc (Yibo) is a Chinese electronics engineering services company focused on PCB design, high-speed circuit layout, and related hardware development support.
Deep TechHardwareRoboticsShenzhen, CN
EurekaBio develops technologies and solutions for the cell and gene therapy (CGT) industry, focused on treatments for diseases such as cancer, rare diseases, genetic disorders, and auto-immune conditions.
BiotechDeep TechHardwareHealthtechMedical DevicesShenzhen, CN
Co-investorsF-Prime Capital
Chengdu-based developer of AAV-based gene therapies for conditions such as AMD and XLRS.
Gordian Surgical develops innovative wound closure solutions for laparoscopic and robotic surgeries, designed to enhance surgical efficiency and patient outcomes.
HardwareMedical Devices
Co-investorsTrendlines GroupVirtus Inspire Ventures
Human Xtensions develops HandX, a handheld surgical device with detachable single-use instruments intended to bridge the gap between laparoscopic and robotic surgery.
HardwareHealthtechMedical Devices
Miracor develops PiCSO (Pressure-controlled intermittent Coronary Sinus Occlusion), a therapy used during percutaneous coronary intervention (PCI) to treat acute myocardial infarction patients.
HealthtechMedical Devices
Co-investorsDelta PartnersQuest for Growth
PEDaily is a Chinese investment news platform that publishes weekly venture capital and startup funding announcements, covering companies across sectors including artificial intelligence, semiconductors, robotics, and biotechnology.
FintechMedia & Entertainment
Co-investorsFortune Venture Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Binghui BiopharmaBinhui BiopharmaCarbon EnergyCucopKeystone HeartSupoinSVisionSVision Imaging
Frequently asked questions
- How many investments has Ming capital made?
- Ming capital has 17 tracked investments.
- What stage does Ming capital invest at?
- Ming capital invests at the Seed, Series A, Series B, Series C, Late Stage stages.
- What sectors does Ming capital focus on?
- Ming capital focuses on Biotech, Digital Health, Healthtech, Medical Devices, Robotics.
- Where is Ming capital located?
- Ming capital is headquartered in Shenzhen, CN.
- Who does Ming capital co-invest with?
- Ming capital most often shares deals with China Growth Capital, Early Light Ventures, F-Prime Capital, among 13 tracked co-investors.
Images
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Norwest Venture Partners is an investment firm whose growth equity team backs private, profitable, fast-growing companies, providing capital and hands-on support through its 'invited guest' approach.
Alumni Ventures (AV) is a venture capital firm that co-invests alongside lead VCs in startups, backing founders with capital and access to a large investor and operator community.